NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

幹細胞-全球市場預測(2020∼2028年)

Stem Cells - Global Market Outlook (2020-2028)

出版商 Stratistics Market Research Consulting 商品編碼 1015167
出版日期 內容資訊 英文 150+ Pages
商品交期: 2-3個工作天內
價格
幹細胞-全球市場預測(2020∼2028年) Stem Cells - Global Market Outlook (2020-2028)
出版日期: 2021年05月05日內容資訊: 英文 150+ Pages
簡介

全球幹細胞的市場規模2020年估算為237億3千萬美金。

該市場在預測期間內預計將以18.6%的年複合成長率增長,2028年前將達到929億1千萬美元。不斷發展的療法監管框架、全球慢性病患病率的增加、公私投資的增加以及對幹細胞研究的資助正在推動市場增長。然而,幹細胞療法的低接受率、與幹細胞製造和銀行業務相關的巨額運營成本正在阻礙市場的增長。

本報告提供幹細胞市場相關調查,提供市場概要,以及不同治療,各產品,科技,各類服務,各用途,應用各領域,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 序文

第3章 市場趨勢分析

  • 簡介
  • 促進因素
  • 阻礙因素
  • 市場機會
  • 威脅
  • 產品分析
  • 科技分析
  • 用途分析
  • 終端用戶分析
  • 新興市場
  • Covid-19的影響

第4章 波特五力分析

第5章 全球幹細胞市場:不同治療

  • 簡介
  • 自動邏輯幹細胞治療
  • 同基因幹細胞治療
  • 同類幹細胞治療

第6章 全球幹細胞市場:各產品

  • 簡介
  • 成體幹細胞(ASC)
    • 臍帶幹細胞/胎兒幹細胞
    • 胎盤來源幹細胞
    • 牙科用幹細胞
    • 間充質(脂肪幹細胞)
    • 造血
    • 表皮/皮膚
    • 神經幹細胞
    • 去分化脂肪 (DFAT) 細胞
  • 非常小的胚胎樣幹細胞
  • 天然花環細胞
  • 誘導性多功能幹細胞(iPSC)
  • 人類胚胎幹細胞(HESC)

第7章 全球幹細胞市場:各科技

  • 簡介
  • 細胞獲得
    • 臍帶血
    • 骨髓收穫
    • 血球分離
  • 電池單元生產
    • 幹細胞培養
    • 隔離
    • 體細胞核移植/治療的基因複製
    • 體外受精
  • 擴張和亞文化
  • 凍結保存

第8章 全球幹細胞市場:各類服務

  • 簡介
  • 特性評估服務
    • 幹細胞自訂服務
    • 人類白血球抗原(HLA)typing服務
    • 幹細胞自訂抗體服務
  • 幹細胞的取得和試驗
  • 藥物篩檢和目標檢驗
  • 分子生物學
  • 幹細胞銀行

第9章 全球幹細胞市場:各用途

  • 簡介
  • 藥物研發與開發
  • 再生醫療
    • 軟組織的損傷和創傷
    • 整形外科治療
    • 血液學
    • 神經學的障礙
    • 肝損傷
    • 失禁
    • 腫瘤學障礙
    • 糖尿病
    • 心血管及心肌梗塞

第10章 全球幹細胞市場:各應用領域野地

  • 簡介
  • 受託調查機關(CRO)
  • 製藥公司/生物科技企業

第11章 全球幹細胞市場:各終端用戶

  • 簡介
  • 病的治療
  • 醫療保健

第12章 全球幹細胞市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他
  • 南美
    • 阿根廷
    • 巴西
    • 智利
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他

第13章 主要發展

  • 契約,夥伴關係,合作,合資企業
  • 收購與合併
  • 新產品的銷售
  • 擴張
  • 其他的重要策略

第14章 企業簡介

  • Virgin Health Bank
  • ThermoGenesis Holdings
  • Stemcell Technologies
  • Caladrius Biosciences, Inc.
  • RENEURON GROUP PLC
  • Precious Cells International Ltd
  • Celgene
  • Opexa Therapeutics
  • Mesoblast
  • Lineage Cell Therapeutics
  • Cellular Engineering Technologies
  • Seneca Biopharmaceuticals, Inc.
  • Pluristem Therapeutics Inc.
  • Biovault family
  • Astellas Pharma
目錄

According to Stratistics MRC, the Global Stem Cells Market is accounted for $23.73 billion in 2020 and is expected to reach $92.91 billion by 2028 growing at a CAGR of 18.6% during the forecast period. Evolving regulatory frameworks for stem cell therapeutics, an increase in the prevalence of chronic diseases worldwide, growing public-private investments, and funding in stem cell-based research are driving the market growth. However, the low acceptance rate for stem cell therapy treatments, significant operational costs associated with stem cell manufacturing and banking are hampering the growth of the market.

Stem cells possess the potential to develop into different types of cells within the body and are also used to make tissues and cells for treating several diseases. Stem cells are the autologous or allogenic cells that can grow into many types of cells in the in-vivo and in-vitro environment. Stem cell therapy is designed to aid the physician in performing medical treatment of neurodegenerative diseases, diabetes, and heart disease.

Based on the product, the induced pluripotent stem cells (iPSCs) segment is going to have lucrative growth during the forecast period due to the increasing investment for developing regenerative medicines using iPSC, ensured reproducibility and maintenance, capable of differentiation into all the cell types and high proliferative ability and the gaining importance of iPSCs in the treatment of various diseases. By geography, North America is going to have high growth during the forecast period owing to the presence of key players engaged in developing stem cell therapies, advanced healthcare infrastructure, extensive R&D, supportive reforms from healthcare organizations, and strong reimbursement policies.

Some of the key players profiled in the Stem Cells Market include Virgin Health Bank, ThermoGenesis Holdings, Stemcell Technologies, Caladrius Biosciences, Inc., RENEURON GROUP PLC, Precious Cells International Ltd, Celgene, Opexa Therapeutics, Mesoblast, Lineage Cell Therapeutics, Cellular Engineering Technologies, Seneca Biopharmaceuticals, Inc., Pluristem Therapeutics Inc., Biovault family and Astellas Pharma.

Therapies Covered:

  • Auto Logic Stem Cell Therapy
  • Syngeneic Stem Cell Therapy
  • Allogeneic Stem Cell Therapy

Products Covered:

  • Adult Stem Cells (ASCs)
  • Very Small Embryonic Like Stem Cells
  • Natural Rosette Cells
  • Induced Pluripotent Stem Cells (iPSCs)
  • Human Embryonic Stem Cells (HESCs)

Technologies Covered:

  • Cell Acquisition
  • Cell Production
  • Expansion and Sub-Culture
  • Cryopreservation

Services Covered:

  • Characterization Services
  • Stem Cell Acquisition & Testing
  • Drug Screening & Target Validation
  • Molecular Biology
  • Stem Cell Banking

Applications Covered:

  • Drug Discovery and Development
  • Regenerative Medicine

Application Areas Covered:

  • Contract Research Organisation (CRO)
  • Pharmaceutical/Biotechnology Companies

End Users Covered:

  • Diseases Therapy
  • Healthcare

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Stem Cells Market, By Therapy

  • 5.1 Introduction
  • 5.2 Auto Logic Stem Cell Therapy
  • 5.3 Syngeneic Stem Cell Therapy
  • 5.4 Allogeneic Stem Cell Therapy

6 Global Stem Cells Market, By Product

  • 6.1 Introduction
  • 6.2 Adult Stem Cells (ASCs)
    • 6.2.1 Umbilical Cord Stem Cells/Fetal Stem Cells
    • 6.2.2 Placenta Derived Stem Cells
    • 6.2.3 Dental Stem Cells
    • 6.2.4 Mesenchymal (Adipose-derived Stem Cells)
    • 6.2.5 Hematopoietic
    • 6.2.6 Epithelial/Skin
    • 6.2.7 Neuronal Stem Cells ( Mouse/Rat Neural)
    • 6.2.8 Dedifferentiated Fat (DFAT) Cells
  • 6.3 Very Small Embryonic Like Stem Cells
  • 6.4 Natural Rosette Cells
  • 6.5 Induced Pluripotent Stem Cells (iPSCs)
  • 6.6 Human Embryonic Stem Cells (HESCs)

7 Global Stem Cells Market, By Technology

  • 7.1 Introduction
  • 7.2 Cell Acquisition
    • 7.2.1 Umbilical Blood Cord
    • 7.2.2 Bone Marrow Harvest
    • 7.2.3 Apheresis
  • 7.3 Cell Production
    • 7.3.1 Stem Cell Culture
    • 7.3.2 Isolation
    • 7.3.3 Somatic Nuclear Transfer / Therapeutic Cloning
    • 7.3.4 In-vitro Fertilization
  • 7.4 Expansion and Sub-Culture
  • 7.5 Cryopreservation

8 Global Stem Cells Market, By Services

  • 8.1 Introduction
  • 8.2 Characterization Services
    • 8.2.1 Stem Cell Custom Services
    • 8.2.2 Human Leukocyte Antigen (HLA) Typing Services
    • 8.2.3 Stem Cell Custom Antibody Services
  • 8.3 Stem Cell Acquisition & Testing
  • 8.4 Drug Screening & Target Validation
  • 8.5 Molecular Biology
  • 8.6 Stem Cell Banking

9 Global Stem Cells Market, By Application

  • 9.1 Introduction
  • 9.2 Drug Discovery and Development
  • 9.3 Regenerative Medicine
    • 9.3.1 Soft Tissue Injuries and Wounds
    • 9.3.2 Orthopedic Treatments
    • 9.3.3 Hematology
    • 9.3.4 Neurological Disorders
    • 9.3.5 Liver Disorder
    • 9.3.6 Incontinence
    • 9.3.7 Oncology Disorders
    • 9.3.8 Diabetes
    • 9.3.9 Cardiovascular and Myocardial Infraction

10 Global Stem Cells Market, By Application Area

  • 10.1 Introduction
  • 10.2 Contract Research Organisation (CRO)
  • 10.3 Pharmaceutical/Biotechnology Companies

11 Global Stem Cells Market, By End User

  • 11.1 Introduction
  • 11.2 Diseases Therapy
  • 11.3 Healthcare

12 Global Stem Cells Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Virgin Health Bank
  • 14.2 ThermoGenesis Holdings
  • 14.3 Stemcell Technologies
  • 14.4 Caladrius Biosciences, Inc.
  • 14.5 RENEURON GROUP PLC
  • 14.6 Precious Cells International Ltd
  • 14.7 Celgene
  • 14.8 Opexa Therapeutics
  • 14.9 Mesoblast
  • 14.10 Lineage Cell Therapeutics
  • 14.11 Cellular Engineering Technologies
  • 14.12 Seneca Biopharmaceuticals, Inc.
  • 14.13 Pluristem Therapeutics Inc.
  • 14.14 Biovault family
  • 14.15 Astellas Pharma

List of Tables

  • Table 1 Global Stem Cells Market Outlook, By Region (2019-2028) ($MN)
  • Table 2 Global Stem Cells Market Outlook, By Therapy (2019-2028) ($MN)
  • Table 3 Global Stem Cells Market Outlook, By Auto Logic Stem Cell Therapy (2019-2028) ($MN)
  • Table 4 Global Stem Cells Market Outlook, By Syngeneic Stem Cell Therapy (2019-2028) ($MN)
  • Table 5 Global Stem Cells Market Outlook, By Allogeneic Stem Cell Therapy (2019-2028) ($MN)
  • Table 6 Global Stem Cells Market Outlook, By Product (2019-2028) ($MN)
  • Table 7 Global Stem Cells Market Outlook, By Adult Stem Cells (ASCs) (2019-2028) ($MN)
  • Table 8 Global Stem Cells Market Outlook, By Umbilical Cord Stem Cells/Fetal Stem Cells (2019-2028) ($MN)
  • Table 9 Global Stem Cells Market Outlook, By Placenta Derived Stem Cells (2019-2028) ($MN)
  • Table 10 Global Stem Cells Market Outlook, By Dental Stem Cells (2019-2028) ($MN)
  • Table 11 Global Stem Cells Market Outlook, By Mesenchymal (Adipose-derived Stem Cells) (2019-2028) ($MN)
  • Table 12 Global Stem Cells Market Outlook, By Hematopoietic (2019-2028) ($MN)
  • Table 13 Global Stem Cells Market Outlook, By Epithelial/Skin (2019-2028) ($MN)
  • Table 14 Global Stem Cells Market Outlook, By Neuronal Stem Cells ( Mouse/Rat Neural) (2019-2028) ($MN)
  • Table 15 Global Stem Cells Market Outlook, By Dedifferentiated Fat (DFAT) Cells (2019-2028) ($MN)
  • Table 16 Global Stem Cells Market Outlook, By Very Small Embryonic Like Stem Cells (2019-2028) ($MN)
  • Table 17 Global Stem Cells Market Outlook, By Natural Rosette Cells (2019-2028) ($MN)
  • Table 18 Global Stem Cells Market Outlook, By Induced Pluripotent Stem Cells (iPSCs) (2019-2028) ($MN)
  • Table 19 Global Stem Cells Market Outlook, By Human Embryonic Stem Cells (HESCs) (2019-2028) ($MN)
  • Table 20 Global Stem Cells Market Outlook, By Technology (2019-2028) ($MN)
  • Table 21 Global Stem Cells Market Outlook, By Cell Acquisition (2019-2028) ($MN)
  • Table 22 Global Stem Cells Market Outlook, By Umbilical Blood Cord (2019-2028) ($MN)
  • Table 23 Global Stem Cells Market Outlook, By Bone Marrow Harvest (2019-2028) ($MN)
  • Table 24 Global Stem Cells Market Outlook, By Apheresis (2019-2028) ($MN)
  • Table 25 Global Stem Cells Market Outlook, By Cell Production (2019-2028) ($MN)
  • Table 26 Global Stem Cells Market Outlook, By Stem Cell Culture (2019-2028) ($MN)
  • Table 27 Global Stem Cells Market Outlook, By Isolation (2019-2028) ($MN)
  • Table 28 Global Stem Cells Market Outlook, By Somatic Nuclear Transfer / Therapeutic Cloning (2019-2028) ($MN)
  • Table 29 Global Stem Cells Market Outlook, By In-vitro Fertilization (2019-2028) ($MN)
  • Table 30 Global Stem Cells Market Outlook, By Expansion and Sub-Culture (2019-2028) ($MN)
  • Table 31 Global Stem Cells Market Outlook, By Cryopreservation (2019-2028) ($MN)
  • Table 32 Global Stem Cells Market Outlook, By Services (2019-2028) ($MN)
  • Table 33 Global Stem Cells Market Outlook, By Characterization Services (2019-2028) ($MN)
  • Table 34 Global Stem Cells Market Outlook, By Stem Cell Custom Services (2019-2028) ($MN)
  • Table 35 Global Stem Cells Market Outlook, By Human Leukocyte Antigen (HLA) Typing Services (2019-2028) ($MN)
  • Table 36 Global Stem Cells Market Outlook, By Stem Cell Custom Antibody Services (2019-2028) ($MN)
  • Table 37 Global Stem Cells Market Outlook, By Stem Cell Acquisition & Testing (2019-2028) ($MN)
  • Table 38 Global Stem Cells Market Outlook, By Drug Screening & Target Validation (2019-2028) ($MN)
  • Table 39 Global Stem Cells Market Outlook, By Molecular Biology (2019-2028) ($MN)
  • Table 40 Global Stem Cells Market Outlook, By Stem Cell Banking (2019-2028) ($MN)
  • Table 41 Global Stem Cells Market Outlook, By Application (2019-2028) ($MN)
  • Table 42 Global Stem Cells Market Outlook, By Drug Discovery and Development (2019-2028) ($MN)
  • Table 43 Global Stem Cells Market Outlook, By Regenerative Medicine (2019-2028) ($MN)
  • Table 44 Global Stem Cells Market Outlook, By Soft Tissue Injuries and Wounds (2019-2028) ($MN)
  • Table 45 Global Stem Cells Market Outlook, By Orthopedic Treatments (2019-2028) ($MN)
  • Table 46 Global Stem Cells Market Outlook, By Hematology (2019-2028) ($MN)
  • Table 47 Global Stem Cells Market Outlook, By Neurological Disorders (2019-2028) ($MN)
  • Table 48 Global Stem Cells Market Outlook, By Liver Disorder (2019-2028) ($MN)
  • Table 49 Global Stem Cells Market Outlook, By Incontinence (2019-2028) ($MN)
  • Table 50 Global Stem Cells Market Outlook, By Oncology Disorders (2019-2028) ($MN)
  • Table 51 Global Stem Cells Market Outlook, By Diabetes (2019-2028) ($MN)
  • Table 52 Global Stem Cells Market Outlook, By Cardiovascular and Myocardial Infraction (2019-2028) ($MN)
  • Table 53 Global Stem Cells Market Outlook, By Application Area (2019-2028) ($MN)
  • Table 54 Global Stem Cells Market Outlook, By Contract Research Organisation (CRO) (2019-2028) ($MN)
  • Table 55 Global Stem Cells Market Outlook, By Pharmaceutical/Biotechnology Companies (2019-2028) ($MN)
  • Table 56 Global Stem Cells Market Outlook, By End User (2019-2028) ($MN)
  • Table 57 Global Stem Cells Market Outlook, By Diseases Therapy (2019-2028) ($MN)
  • Table 58 Global Stem Cells Market Outlook, By Healthcare (2019-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.